A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 - Related Studies

A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248

This study is currently recruiting participants.

Study NCT00094029. Last updated on November 16, 2008. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Gastrointestinal Neoplasm

2	Additional conditions recognized in this trial
		Digestive System Neoplasms
		Gastrointestinal Neoplasms
		Gastrointestinal Stromal Tumors

3	More general conditions related to this trial
		Digestive System Diseases
		Gastrointestinal Diseases
		Neoplasms
		Neoplasms by Site

4	Interventions listed in this trial
		SU011248

5	Additional drug interventions recognized in this trial
		Sunitinib

6	More general drug interventions related to this trial
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Antineoplastic Agents
		Growth Inhibitors
		Growth Substances
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Pfizer